“We urge HHS, FDA, DHS, and CBP to delay any implementation of new procedures with respect to prescription medicines unless you can provide clear assurances that your agencies will not prevent genuine prescription medicines clearly intended for personal use and not appearing to present an unreasonable risk from entering the United States,” the members added.
Urge federal health and border agencies to delay new prescription-medicine import procedures unless they can assure continued entry of genuine personal-use prescription medicines that do not present unreasonable risk.
Occurrences
Evidence
unverified · Source version 79214 · locator unknown
“We urge HHS, FDA, DHS, and CBP to delay any implementation of new procedures with respect to prescription medicines”
unverified · Source version 79214 · locator unknown
“Mike Quigley (IL-05), Delia Ramirez (IL-03), Emily Randall (WA-06)”
unverified · Source version 90750 · locator unknown
“We urge HHS, FDA, DHS, and CBP to delay any implementation of new procedures with respect to prescription medicines unless you can provide clear assurances”
unverified · Source version 90750 · locator unknown
“Mike Quigley (IL-05), Delia Ramirez (IL-03), Emily Randall (WA-06)”
Assessments
No assessments yet.